Position in ABBV
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$497,995
+$58,231 QoQ
Shares Held
1,979
-2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#3,160
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Acorn Wealth Advisors, LLC holds $4,229,876 across 7 Drug Manufacturers - General names. ABBV ranks #5 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,833 | $973,467 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,368 | $818,288 | |
| 3 | LLY |
ELI LILLY & Co
|
620 | $743,646 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
8,764 | $504,981 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
1,979 | $497,995 | |
| 6 | PFE |
Pfizer Inc
|
14,918 | $359,225 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,630 | $332,274 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $497,995 | 1,979 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $439,764 | 2,022 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $462,920 | 2,026 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $496,190 | 2,143 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $365,114 | 1,967 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $416,735 | 1,989 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $359,842 | 2,025 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $412,535 | 2,089 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $387,978 | 2,262 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $334,517 | 1,837 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $272,282 | 1,757 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $280,978 | 1,885 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $269,055 | 1,997 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $321,289 | 2,016 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $328,553 | 2,033 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $268,151 | 1,998 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $311,833 | 2,036 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $346,915 | 2,140 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $306,545 | 2,264 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $237,637 | 2,203 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $262,113 | 2,327 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $244,468 | 2,259 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $245,480 | 2,291 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $229,923 | 2,625 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $208,927 | 2,128 | Shares | Sole | 2020-08-19 | |
| No filing history on record for this holder in this stock. | ||||||